Michael J. Worley Jr., MD

For patients with advanced-stage ovarian/fallopian tube/peritoneal cancer, the quality of their initial surgery remains the most influential factor related to long-term survival. My research interests include improving the quality of surgical care delivered to these patients, so both short-term postoperative outcomes, as well as long-term survival, can be optimized.
I have published numerous articles regarding the appropriate use of primary cytoreductive surgery and neoadjuvant chemotherapy. These publications have provided clarity into what patient populations are ideally suited for each treatment approach. In addition, my research efforts have helped refine the overall goals of surgical resection, as well as management strategies to achieve the best surgical outcome.
I have lectured both locally and nationally on the topic of surgical resection of advanced-stage ovarian/fallopian tube/peritoneal cancer. In addition, I have been awarded the Eleanor and Miles Shore 50th Anniversary Fellowship Program for Scholars in Medicine (Harvard Medical School) in support of my research efforts.